Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition. The shortlist includes our DPhil student Magda Mareckova (pictured).

Good luck to our DPhil student Magda Mareckova. Her article: “One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” is shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.

The winner, who will receive a £1,500 prize, will be announced at the awards ceremony on 15 October at the Royal Institution, London.

This year’s judging panel is made up of:

  • MRC Executive Chair Professor Fiona Watt
  • Dr Roger Highfield, MRC Council member and director of external affairs at the Science Museum Group
  • Andy Ridgway, journalist and senior lecturer in science communication at the University of the West of England, Bristol

The Max Perutz Award asks MRC-funded PhD students to write up to 800 words about their research and why it matters, in a way that would interest a non-scientific audience.

More than 100 entries of a very high standard were received this year, which made the shortlisting a challenging task. Congratulations to the following exceptional writers:

  • Magda MareckovaUniversity of Oxford: “One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?”
  • Erin Attrill, Living Systems Institute, University of Exeter: “The enemy of my enemy is my friend”
  • Anna Beukenhorst, MRC Doctoral Training Programme, University of Manchester: “Smartphones for healthcare research data at our fingertips”
  • Imogen Birch, The Cardiff University Brain Research Imaging Centre (CUBRIC): “Get some sleep, you’ll feel better in the morning”
  • Peter Gawne, School of Biomedical Engineering & Imaging Science, Kings College London: “An optimist's guide to radioactivity using medical imaging to develop and improve new treatments”
  • Elisabeth Kent, University of Manchester: “Mixed up messages in the gut”
  • Nora Schmit, School of Public Health, Imperial College London: “Back to the future: how reconstructing the past hepatitis B epidemic can help prevent liver cancer in the future”
  • Amy Southern, MRC Harwell: “Making sense of a sticky situation: finding the 'glue ear gene' in Down syndrome”
  • Lauren Terry, University of Birmingham: “Senolytics - the anti-aging product you've never heard of”
  • Alice Waitt, University of Nottingham: “How to RECOGNeyes your attention”
  • Katrina Wesencraft, The EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging (OPTIMA CDT), Centre for Biophotonics, University of Strathclyde: “Could a cell 'invisibility cloak' help cure diabetes?”
  • Akira Wiberg, University of Oxford: “Getting on your nerves”

The award is named in honour of one of the UK’s most outstanding scientists and communicators, Dr Max Perutz. Max, who died in 2002, was awarded the 1962 Nobel Prize in Chemistry for his work using X-ray crystallography to study the structures of globular proteins. He was the founder and first chairman of the MRC Laboratory of Molecular Biology in Cambridge, the lab which unravelled the structure of DNA. Max was also a keen and talented communicator who inspired countless students to use everyday language to share their research with the people whose lives are improved by their work.

All of the shortlisted articles will be published on the MRC website after the awards ceremony, on 16 October.

Latest news

Targeted Removal of sFlt-1 in Very Preterm Preeclampsia: A Promising First-in-Human Pilot Study

A first-in-human pilot study, published in Nature Medicine, suggests that selectively removing a placenta-derived protein called soluble Fms-like tyrosine kinase 1 (sFlt-1) from the blood may be a safe and feasible way to help manage very preterm preeclampsia.

Oxford to lead Europe's largest miscarriage research centre in partnership with Tommy's

The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.

Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes

Today, on World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes. High-grade serous ovarian cancer is the most common subtype of ovarian cancer, with many patients diagnosed at an advanced stage. Survival outcomes remain closely linked to the stage at which the disease is diagnosed.

Phase 2 Endometriosis Study Highlights a Novel Molecular Imaging Agent as a Promising Diagnostic and Monitoring Tool

A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.

Our Research Groups